2022 Breakthrough Prize in Life Sciences awarded to mRNA pioneers Drew Weissman and Katalin Karikó Twenty-five years ago, Drew Weissman and Katalin Karikó struck up their first conversations at Penn by a copy machine, where both were printing journal articles. That chance encounter laid the foundation for a revolution in mRNA technology, innovations that are now being leveraged to confront a host of biomedical challenges. (Image: Peggy Peterson) 2022 Breakthrough Prize in Life Sciences awarded to mRNA pioneers Drew Weissman and Katalin Karikó Weissman and Karikó are honored for engineering modified RNA technology which enabled rapid development of effective COVID-19 vaccines.
Penn scientists win $3 million Breakthrough Prize for RNA research that enabled COVID-19 vaccines Penn In the News Philadelphia Inquirer Penn scientists win $3 million Breakthrough Prize for RNA research that enabled COVID-19 vaccines Katalin Karikó and Drew Weissman of the Perelman School of Medicine have been awarded a $3 million Breakthrough Prize for research that paved the way for COVID-19 vaccines. “It’s been very wonderful,” said Weissman. “I never thought it was possible.” State vaccine incentives do little to boost vaccination rates, research shows Penn In the News CBS News State vaccine incentives do little to boost vaccination rates, research shows Research from Penn’s Center for Health Incentives and Behavioral Economics found that incentives like cash lotteries and scholarships don’t boost vaccination rates. “We did not see more people coming into get vaccinated in the immediate aftermath of the introduction of these statewide incentives," said Harsha Thirumurthy of the Perelman School of Medicine. COVID-19 presents an understanding of nurses’ moral distress during crisis care COVID-19 presents an understanding of nurses’ moral distress during crisis care Researchers from the School of Nursing found that effective leadership and communication reduced moral distress for nurses providing patients with crisis care during the pandemic. Penn mRNA researchers Drew Weissman and Katalin Karikó awarded the 2021 Albany Prize Drew Weissman, the Roberts Family Professor of Vaccine Research, and Katalin Karikó, an adjunct professor of Neurosurgery at the Perelman School of Medicine and a senior vice president at BioNTech. (Image: Penn Medicine News) Penn mRNA researchers Drew Weissman and Katalin Karikó awarded the 2021 Albany Prize For their landmark research that set a foundation for the mRNA SARS-CoV-2 vaccines, Drew Weissman and Katalin Karikó have been selected to receive the prize after decades of work. COVID-19 mRNA vaccine that uses fundamental Penn technology receives FDA approval Katalin Karikó, an adjunct professor of Neurosurgery at Penn and a senior vice president at BioNTech, and Drew Weissman, the Roberts Family Professor in Vaccine Research. (Image: Penn Medicine News) COVID-19 mRNA vaccine that uses fundamental Penn technology receives FDA approval Pfizer/BioNTech’s vaccine to prevent COVID-19 uses fundamental modified mRNA technology created by Drew Weissman and Katalin Karikó at the Perelman School of Medicine. The F.D.A. grants full approval to the Pfizer-BioNTech Covid-19 vaccine Penn In the News The New York Times The F.D.A. grants full approval to the Pfizer-BioNTech Covid-19 vaccine Alison Buttenheim of the School of Nursing is quoted on the rates of vaccine hesitancy despite FDA vaccine approval. Have you already had a breakthrough COVID infection? Penn In the News The New Yorker Have you already had a breakthrough COVID infection? Jeffrey Morris of the Perelman School of Medicine says the efficacy rate of vaccines are actually higher than reported. Penn study details robust T-cell response to mRNA COVID-19 vaccines Penn study details robust T-cell response to mRNA COVID-19 vaccines The results underline the importance of a second dose and include implications for booster shots. Engineers create faster and cheaper COVID-19 testing with pencil lead César de la Fuente, Presidential Assistant Professor Engineers create faster and cheaper COVID-19 testing with pencil lead A new electrochemical COVID-19 test addresses the challenges of cost, time, and accuracy and uses electrodes made from graphite. Load More
State vaccine incentives do little to boost vaccination rates, research shows Penn In the News CBS News State vaccine incentives do little to boost vaccination rates, research shows Research from Penn’s Center for Health Incentives and Behavioral Economics found that incentives like cash lotteries and scholarships don’t boost vaccination rates. “We did not see more people coming into get vaccinated in the immediate aftermath of the introduction of these statewide incentives," said Harsha Thirumurthy of the Perelman School of Medicine. COVID-19 presents an understanding of nurses’ moral distress during crisis care COVID-19 presents an understanding of nurses’ moral distress during crisis care Researchers from the School of Nursing found that effective leadership and communication reduced moral distress for nurses providing patients with crisis care during the pandemic. Penn mRNA researchers Drew Weissman and Katalin Karikó awarded the 2021 Albany Prize Drew Weissman, the Roberts Family Professor of Vaccine Research, and Katalin Karikó, an adjunct professor of Neurosurgery at the Perelman School of Medicine and a senior vice president at BioNTech. (Image: Penn Medicine News) Penn mRNA researchers Drew Weissman and Katalin Karikó awarded the 2021 Albany Prize For their landmark research that set a foundation for the mRNA SARS-CoV-2 vaccines, Drew Weissman and Katalin Karikó have been selected to receive the prize after decades of work. COVID-19 mRNA vaccine that uses fundamental Penn technology receives FDA approval Katalin Karikó, an adjunct professor of Neurosurgery at Penn and a senior vice president at BioNTech, and Drew Weissman, the Roberts Family Professor in Vaccine Research. (Image: Penn Medicine News) COVID-19 mRNA vaccine that uses fundamental Penn technology receives FDA approval Pfizer/BioNTech’s vaccine to prevent COVID-19 uses fundamental modified mRNA technology created by Drew Weissman and Katalin Karikó at the Perelman School of Medicine. The F.D.A. grants full approval to the Pfizer-BioNTech Covid-19 vaccine Penn In the News The New York Times The F.D.A. grants full approval to the Pfizer-BioNTech Covid-19 vaccine Alison Buttenheim of the School of Nursing is quoted on the rates of vaccine hesitancy despite FDA vaccine approval. Have you already had a breakthrough COVID infection? Penn In the News The New Yorker Have you already had a breakthrough COVID infection? Jeffrey Morris of the Perelman School of Medicine says the efficacy rate of vaccines are actually higher than reported. Penn study details robust T-cell response to mRNA COVID-19 vaccines Penn study details robust T-cell response to mRNA COVID-19 vaccines The results underline the importance of a second dose and include implications for booster shots. Engineers create faster and cheaper COVID-19 testing with pencil lead César de la Fuente, Presidential Assistant Professor Engineers create faster and cheaper COVID-19 testing with pencil lead A new electrochemical COVID-19 test addresses the challenges of cost, time, and accuracy and uses electrodes made from graphite. Load More
COVID-19 presents an understanding of nurses’ moral distress during crisis care COVID-19 presents an understanding of nurses’ moral distress during crisis care Researchers from the School of Nursing found that effective leadership and communication reduced moral distress for nurses providing patients with crisis care during the pandemic.
Penn mRNA researchers Drew Weissman and Katalin Karikó awarded the 2021 Albany Prize Drew Weissman, the Roberts Family Professor of Vaccine Research, and Katalin Karikó, an adjunct professor of Neurosurgery at the Perelman School of Medicine and a senior vice president at BioNTech. (Image: Penn Medicine News) Penn mRNA researchers Drew Weissman and Katalin Karikó awarded the 2021 Albany Prize For their landmark research that set a foundation for the mRNA SARS-CoV-2 vaccines, Drew Weissman and Katalin Karikó have been selected to receive the prize after decades of work.
COVID-19 mRNA vaccine that uses fundamental Penn technology receives FDA approval Katalin Karikó, an adjunct professor of Neurosurgery at Penn and a senior vice president at BioNTech, and Drew Weissman, the Roberts Family Professor in Vaccine Research. (Image: Penn Medicine News) COVID-19 mRNA vaccine that uses fundamental Penn technology receives FDA approval Pfizer/BioNTech’s vaccine to prevent COVID-19 uses fundamental modified mRNA technology created by Drew Weissman and Katalin Karikó at the Perelman School of Medicine.
The F.D.A. grants full approval to the Pfizer-BioNTech Covid-19 vaccine Penn In the News The New York Times The F.D.A. grants full approval to the Pfizer-BioNTech Covid-19 vaccine Alison Buttenheim of the School of Nursing is quoted on the rates of vaccine hesitancy despite FDA vaccine approval. Have you already had a breakthrough COVID infection? Penn In the News The New Yorker Have you already had a breakthrough COVID infection? Jeffrey Morris of the Perelman School of Medicine says the efficacy rate of vaccines are actually higher than reported. Penn study details robust T-cell response to mRNA COVID-19 vaccines Penn study details robust T-cell response to mRNA COVID-19 vaccines The results underline the importance of a second dose and include implications for booster shots. Engineers create faster and cheaper COVID-19 testing with pencil lead César de la Fuente, Presidential Assistant Professor Engineers create faster and cheaper COVID-19 testing with pencil lead A new electrochemical COVID-19 test addresses the challenges of cost, time, and accuracy and uses electrodes made from graphite. Load More
Have you already had a breakthrough COVID infection? Penn In the News The New Yorker Have you already had a breakthrough COVID infection? Jeffrey Morris of the Perelman School of Medicine says the efficacy rate of vaccines are actually higher than reported. Penn study details robust T-cell response to mRNA COVID-19 vaccines Penn study details robust T-cell response to mRNA COVID-19 vaccines The results underline the importance of a second dose and include implications for booster shots. Engineers create faster and cheaper COVID-19 testing with pencil lead César de la Fuente, Presidential Assistant Professor Engineers create faster and cheaper COVID-19 testing with pencil lead A new electrochemical COVID-19 test addresses the challenges of cost, time, and accuracy and uses electrodes made from graphite.
Penn study details robust T-cell response to mRNA COVID-19 vaccines Penn study details robust T-cell response to mRNA COVID-19 vaccines The results underline the importance of a second dose and include implications for booster shots.
Engineers create faster and cheaper COVID-19 testing with pencil lead César de la Fuente, Presidential Assistant Professor Engineers create faster and cheaper COVID-19 testing with pencil lead A new electrochemical COVID-19 test addresses the challenges of cost, time, and accuracy and uses electrodes made from graphite.